Mds Podcast
A post-hoc analysis of the Prasinezumab trial in early Parkinson's disease
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:00:00
- Mas informaciones
Informações:
Sinopsis
Dr. Gennaro Pagano discusses the findings of the post-hoc analysis of the PASADENA trial, a study using the monoclonal antibody Prasinezumab directed at aggregated α-synuclein, where motor progression trajectories differed between active and placebo groups. Read article »
